In addition, it addresses the FDA’s communications Using the applicant, the retention of data that aid the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of the SE report back to a fresh applicant and Digital submission from the SE report and amendments.Th